173 related articles for article (PubMed ID: 35054078)
1. Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes.
Juchnicka I; Kuźmicki M; Zabielski P; Krętowski A; Błachnio-Zabielska A; Szamatowicz J
J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054078
[TBL] [Abstract][Full Text] [Related]
2. Diverse Sphingolipid Profiles in Rectal and Colon Cancer.
Markowski AR; Błachnio-Zabielska AU; Pogodzińska K; Markowska AJ; Zabielski P
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446046
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis-A Preliminary Study.
Zdanowicz K; Bobrus-Chcociej A; Pogodzinska K; Blachnio-Zabielska A; Zelazowska-Rutkowska B; Lebensztejn DM; Daniluk U
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233480
[TBL] [Abstract][Full Text] [Related]
4. Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysis.
Knapp P; Bodnar L; Błachnio-Zabielska A; Reszeć J; Świderska M; Chabowski A
Arch Med Sci; 2021; 17(1):53-61. PubMed ID: 33488856
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis.
Charkiewicz K; Goscik J; Blachnio-Zabielska A; Raba G; Sakowicz A; Kalinka J; Chabowski A; Laudanski P
PLoS One; 2017; 12(5):e0177601. PubMed ID: 28542236
[TBL] [Abstract][Full Text] [Related]
6. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
7. Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer.
Knapp P; Bodnar L; Błachnio-Zabielska A; Świderska M; Chabowski A
Gynecol Oncol; 2017 Oct; 147(1):139-144. PubMed ID: 28800942
[TBL] [Abstract][Full Text] [Related]
8. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
9. Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.
Charkiewicz K; Blachnio-Zabielska A; Zbucka-Kretowska M; Wolczynski S; Laudanski P
PLoS One; 2015; 10(5):e0127732. PubMed ID: 26000716
[TBL] [Abstract][Full Text] [Related]
10. Maternal plasma diacylglycerols and triacylglycerols in the prediction of gestational diabetes mellitus.
Hou G; Gao Y; Poon LC; Ren Y; Zeng C; Wen B; Syngelaki A; Lin L; Zi J; Su F; Xie W; Chen F; Nicolaides KH
BJOG; 2023 Feb; 130(3):247-256. PubMed ID: 36156361
[TBL] [Abstract][Full Text] [Related]
11. Ceramide Content in Liver Increases Along with Insulin Resistance in Obese Patients.
Razak Hady H; Błachnio-Zabielska AU; Szczerbiński Ł; Zabielski P; Imierska M; Dadan J; Krętowski AJ
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31842461
[TBL] [Abstract][Full Text] [Related]
12. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
[TBL] [Abstract][Full Text] [Related]
13. Gas Chromatography-Mass Spectroscopy-Based Metabolomics Analysis Reveals Potential Biochemical Markers for Diagnosis of Gestational Diabetes Mellitus.
Raczkowska BA; Mojsak P; Rojo D; Telejko B; Paczkowska-Abdulsalam M; Hryniewicka J; Zielinska-Maciulewska A; Szelachowska M; Gorska M; Barbas C; Kretowski A; Ciborowski M
Front Pharmacol; 2021; 12():770240. PubMed ID: 34867398
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients.
Aslan İ; Aydın D; Koca Y; Yılmaz Ç; Çeker T; Öztüzün A; Aslan M
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106719. PubMed ID: 36863606
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: A pilot study.
Sokołowska E; Car H; Fiedorowicz A; Szelachowska M; Milewska A; Wawrusiewicz-Kurylonek N; Szumowski P; Krzyżanowska-Grycel E; Popławska-Kita A; Żendzian-Piotrowska M; Chabowski A; Krętowski A; Siewko K
Adv Med Sci; 2022 Sep; 67(2):250-256. PubMed ID: 35785598
[TBL] [Abstract][Full Text] [Related]
16. Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus.
Endo S; Maeda K; Suto M; Kaji T; Morine M; Kinoshita T; Yasui T; Irahara M
Gynecol Endocrinol; 2006 Jun; 22(6):343-9. PubMed ID: 16785160
[TBL] [Abstract][Full Text] [Related]
17. Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke.
Fiedorowicz A; Kozak-Sykała A; Bobak Ł; Kałas W; Strządała L
Neurol Neurochir Pol; 2019; 53(6):484-491. PubMed ID: 31804702
[TBL] [Abstract][Full Text] [Related]
18. Ramadan intermittent fasting is associated with ameliorated inflammatory markers and improved plasma sphingolipids/ceramides in subjects with obesity: lipidomics analysis.
Madkour MI; Islam MT; Tippetts TS; Chowdhury KH; Lesniewski LA; Summers SA; Zeb F; Abdelrahim DN; AlKurd R; Khraiwesh HM; AbuShihab KH; AlBakri A; Obaideen K; Faris ME
Sci Rep; 2023 Oct; 13(1):17322. PubMed ID: 37833312
[TBL] [Abstract][Full Text] [Related]
19. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy.
Kautzky-Willer A; Prager R; Waldhausl W; Pacini G; Thomaseth K; Wagner OF; Ulm M; Streli C; Ludvik B
Diabetes Care; 1997 Nov; 20(11):1717-23. PubMed ID: 9353615
[TBL] [Abstract][Full Text] [Related]
20. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
